Tempus AI, Inc
$683.5K 14,627 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
SNAP Diagnostics LLC
SNAP Diagnostics LLC reported $687,164.18 across General Payments, Research, and Ownership to 77 physicians and teaching hospitals across 78 transactions.
- $687.2K
- All-tracks total
- 78
- Transactions
- 77
- Recipients
- +$38.2K
- General Payments vs PY2023
SNAP Diagnostics LLC reported $687,164.18 across all CMS Open Payments tracks (General + Research + Ownership) to 77 physicians and teaching hospitals in Program Year 2024 - ranking #696 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $514,953.88, averaging $8.9K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer snap-diagnostics-llc SNAP Diagnostics LLC
$687.2K · #696/1,925 · 0.0% industry · PY2024
- TOT $687.2K
- RANK #696
- SHARE 0.0%
- TXN 78
- RCP 77
- CAT 2
- GEN $515.0K
- ΔGEN +$38.2K
- TOP1 38.9%
- PY 2024
Volume peers
Nearest volume peer: Tempus AI, Inc ($683.5K)
SNAP Diagnostics LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
SNAP Diagnostics LLC's CMS-reported General Payments increased by $38.2K (+8.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: SNAP DIAGNOSTICS LLCPY2023: SNAP DIAGNOSTICS LLCPY2024: SNAP Diagnostics LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $476,782.01
- PY2024
- $514,953.88
What the Data Shows for SNAP Diagnostics LLC
$687,164.18: that is what SNAP Diagnostics LLC reported in payments to 77 physicians and teaching hospitals during Program Year 2024, spread across 78 transactions ($8.8K per transaction, $8.9K per recipient). The company sits at rank #696 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Compensation for Services Other Than Consulting" at $514.9K, accounting for 100.0% of this company's General Payments and 72 transactions.
General Payment Breakdown by Type
SNAP Diagnostics LLC made 2 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $514.9K, 100.0% of General Payments.
How SNAP Diagnostics LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $514.9K | 72 | 100.0% |
| Food and Beverage | $72.88 | 5 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $475,776.00 (92.4%) of $514,953.88 in this company's General Payments records across 11 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for SNAP Diagnostics LLC
The five named recipients with the highest reported General Payments from this company
- 1
Lisa Shives
$200,304.00 across 12 reported transactions
- 2
Roukan Jazayerli
$102,675.00 across 12 reported transactions
- 3
Muhammad Najjar
$80,497.00 across 12 reported transactions
- 4
Dianne Augelli
$50,000.00 across 12 reported transactions
- 5
Simmy Jerry Pinto
$42,300.00 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as SNAP Diagnostics LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about SNAP Diagnostics LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with SNAP Diagnostics LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Kaneka Medical America LLC
$691.1K 202 recipients
Compare payment profiles
Synapse Surgical LLC
$674.2K 0 recipients
Compare payment profiles
Extremity Medical
$672.9K 438 recipients
Compare payment profiles
Verathon Inc.
$672.8K 134 recipients
Compare payment profiles
Day One Biopharmaceuticals
$703.0K 191 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.